Skip to main content
. 2022 Dec 5;4:100113. doi: 10.1016/j.bjao.2022.100113

Table 3.

Characteristics of the full cohort (n=40 555) and bivariate analyses of patients with and without a clinical diagnosis of heart failure. Data are reported in the form of mean (standard deviation for quantitative variables and n [%] for categorical variables. ∗Classified by Veterans Administration National Drug Formulary Categories. EGFR, estimated glomerular filtration rate; HF, heart failure.

Variable Full cohort (n=40,555) Clinical HF diagnosis (n=3,698) No clinical HF diagnosis (n=36,857) Standardised difference
Age (yr) 62 (12) 68 (120) 61 (11) 0.59
Surgical duration (min) 218 (126) 223 (126) 217 (126) 0.05
Height (cm) 170 (11) 171 (11) 170 (11) 0.06
Weight (kg) 87 (23) 90 (25) 87 (23) 0.15
BMI (kg m−2) 30 (7) 31 (8) 30 (7) 0.13
Baseline MAP (mm Hg) 97 (13) 96 (15) 97 (13) –0.11
Baseline heart rate (beats min−1) 75 (14) 75 (15) 75 (14) –0.01
Baseline ventilatory frequency (bpm) 17 (2) 17 (2) 17 (2) 0.19
Baseline SpO2 (%) 97 (2) 96 (2) 97 (2) –0.17
Preoperative EGFR (L min−1 1.73 m−2) 80 (24) 64 (28) 81 (23) –0.68
Preoperative glucose (mg dl−1) 108 (35) 118 (43) 107 (34) 0.29
Preoperative haemoglobin (g dl−1) 13.3 (2) 12.2 (2.2) 13.4 (1.9) –0.56
Preoperative platelet count (K μl−1) 245 (81) 225 (87) 247 (80) –0.26
Preoperative sodium level (mEq L−1) 140 (3) 139 (4) 140 (3) –0.26
Sex
 Male 20667 (51.0) 2201 (59.5) 18466 (50.1) 0.19
 Female 19886 (49.0) 1497 (40.5) 18389 (49.9)
Race
 Asian or Pacific Islander 903 (2.2) 63 (1.7) 840 (2.3) 0.15
 Black, not of Hispanic origin 2918 (7.2) 392 (10.6) 2526 (6.9)
 Unknown/Other 1503 (3.7) 105 (2.8) 1398 (3.8)
 White, not of Hispanic origin 35231 (86.9) 3138 (84.9) 32093 (87.1)
ASA physical status classification
 1 765 (1.9) 2 (0.1) 763 (2.1) 1.14
 2 15417 (38) 167 (4.5) 15250 (41.4)
 3 22639 (55.9) 2758 (74.6) 19881 (54)
 4 1709 (4.2) 768 (20.8) 941 (2.6)
Emergent surgery
 Emergent 2580 (6.4) 420 (11.4) 2160 (5.9) 0.20
Primary procedural service
 General 7253 (17.9) 550 (14.9) 6703 (18.2) 0.52
 Otolaryngology 5666 (14) 395 (10.7) 5271 (14.3)
 Urology 4905 (12.1) 359 (9.7) 4546 (12.3)
 Orthopaedics 4570 (11.3) 451 (12.2) 4119 (11.2)
 Neurosurgery 4124 (10.2) 278 (7.5) 3846 (10.4)
 Thoracic 2409 (5.9) 238 (6.4) 2171 (5.9)
 Trauma 1953 (4.8) 253 (6.8) 1700 (4.6)
 Obstetrics/gynaecology 1707 (4.2) 91 (2.5) 1616 (4.4)
 Vascular 1622 (4) 416 (11.3) 1206 (3.3)
 Plastics 1596 (3.9) 59 (1.6) 1537 (4.2)
 Ophthalmology 1568 (3.9) 124 (3.4) 1444 (3.9)
 Oral/maxillofacial 1484 (3.7) 117 (3.2) 1367 (3.7)
 Transplant 1067 (2.6) 201 (5.4) 866 (2.4)
 Dentistry 334 (0.8) 20 (0.5) 314 (0.9)
 Other/Unknown 297 (0.7) 146 (4) 151 (0.4)
Comorbidities
 Hypertension 22225 (54.8) 3142 (85) 19083 (51.8) 0.76
 Cancer 14643 (36.1) 1195 (32.3) 13448 (36.5) –0.09
 Diabetes 7980 (19.7) 1442 (39) 6538 (17.7) 0.49
 Chronic pulmonary disease 7868 (19.4) 1240 (33.5) 6628 (18) 0.36
 Cardiac arrhythmia 7565 (18.7) 1856 (50.2) 5709 (15.5) 0.80
 Hypothyroidism 5366 (13.2) 646 (17.5) 4720 (12.8) 0.13
 Renal failure 5054 (12.5) 1436 (38.8) 3618 (9.8) 0.72
 Coronary artery disease 4414 (10.9) 1544 (41.8) 2870 (7.8) 0.86
 Peripheral vascular disorders 3194 (7.9) 1058 (28.6) 2136 (5.8) 0.63
 Liver disease 2594 (6.4) 388 (10.5) 2206 (6) 0.16
 Coagulopathy 2054 (5.1) 476 (12.9) 1578 (4.3) 0.31
 Valvular disease 1721 (4.2) 695 (18.8) 1026 (2.8) 0.53
 Pulmonary circulation disorders 1476 (3.6) 610 (16.5) 866 (2.4) 0.5
 Cerebrovascular disease 1374 (3.4) 295 (8) 1079 (2.9) –0.86
Year of surgery
 2015 4727 (11.7) 441 (11.9) 4286 (11.6) 0.04
 2016 10361 (25.6) 923 (25) 9438 (25.6)
 2017 10541 (26) 933 (25.2) 9608 (26.1)
 2018 10616 (26.2) 967 (26.2) 9649 (26.2)
 2019 4310 (10.6) 434 (11.7) 3876 (10.5)
Home medications
 BL110 – Anticoagulants 3765 (9.3) 1086 (29.4) 2679 (7.3) 0.60
 BL117 – Platelet aggregation inhibitors 1542 (3.8) 434 (11.7) 1108 (3) 0.34
 CN101 – Opioids 4400 (10.9) 538 (14.6) 3862 (10.5) 0.12
 CN103 – Non-opioid analgesics 21490 (53) 2811 (76) 18679 (50.7) 0.54
 CV100 – Beta blockers 11159 (27.5) 2517 (68.1) 8642 (23.5) 1.00
 CV150 – Alpha blockers 3524 (8.7) 528 (14.3) 2996 (8.1) 0.20
 CV200 – Calcium channel blockers 7062 (17.4) 1007 (27.2) 6055 (16.4) 0.26
 CV250 – Anti-anginals 1812 (4.5) 656 (17.7) 1156 (3.1) 0.49
 CV300 – Anti-arrhythmics 2219 (5.5) 474 (12.8) 1745 (4.7) 0.29
 CV350 – Anti-lipaemics 15850 (39.1) 2344 (63.4) 13506 (36.6) 0.56
 CV701 – Thiazide diuretics 6661 (16.4) 548 (14.8) 6113 (16.6) –0.05
 CV702 – Loop diuretics 3216 (7.9) 1471 (39.8) 1745 (4.7) 0.93
 CV704 – Potassium-sparing diuretics 1860 (4.6) 496 (13.4) 1364 (3.7) 0.35
 CV800 – ACE inhibitors 8713 (21.5) 1121 (30.3) 7592 (20.6) 0.22
 CV805 – Angiotensin II inhibitors 4832 (11.9) 695 (18.8) 4137 (11.2) 0.21
 HS851 – Thyroid supplements 6397 (15.8) 718 (19.4) 5679 (15.4) 0.11
 RE102 – Inhaled bronchodilators 6377 (15.7) 915 (24.7) 5462 (14.8) 0.25
Lowest preoperative left ventricular ejection fraction
 Hyperdynamic (≥70%) 14 (2.7) 3 (1.3) 11 (4) –1.89
 Missing or normal (50–69%) 290 (56.8) 54 (22.8) 236 (86.1)
 Mild dysfunction (40–49%) 46 (9) 29 (12.2) 17 (6.2)
 Moderate dysfunction (30–39%) 72 (14.1) 64 (27) 8 (2.9)
 Severe dysfunction (<30%) 89 (17.4) 87 (36.7) 2 (0.7)
Preoperative diastolic dysfunction
 Normal or missing 287 (56.2) 66 (27.9) 221 (80.7) –1.25
 Present (any grade) 224 (43.8) 171 (72.2) 53 (19.3)